NeuroPace Inc. (NPCE) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    NeuroPace Inc.

    NASDAQ: NPCE · Real-Time Price · USD
    10.92
    0.49 (4.70%)
    At close: Oct 03, 2025, 3:59 PM
    10.80
    -1.10%
    After-hours: Oct 03, 2025, 05:09 PM EDT

    NeuroPace Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 79.91M 65.42M 45.52M 45.18M
    Cost of Revenue
    		 20.82M 17.3M 13.03M 11.75M
    Gross Profit
    		 59.09M 48.12M 32.49M 33.44M
    Operating Income
    		 -21.67M -27.17M -40.79M -23.74M
    Interest Income
    		 3.02M 3.05M 1.58M 448K
    Pretax Income
    		 -27.14M -32.96M -47.08M -36.08M
    Net Income
    		 -27.14M -32.96M -47.08M -36.08M
    Selling & General & Admin
    		 57.1M 54.52M 51.34M 38.96M
    Research & Development
    		 23.65M 20.78M 21.95M 18.21M
    Other Expenses
    		 n/a n/a n/a n/a
    Operating Expenses
    		 80.76M 75.3M 73.29M 57.17M
    Interest Expense
    		 8.8M 8.52M 7.53M 7.41M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 101.58M 92.59M 86.31M 68.92M
    Income Tax Expense
    		 n/a n/a 6.29M 2.03M
    Shares Outstanding (Basic)
    		 29.13M 25.85M 24.59M 24.45M
    Shares Outstanding (Diluted)
    		 29.13M 25.85M 24.59M 24.45M
    EPS (Basic)
    		 -0.93 -1.27 -1.91 -1.48
    EPS (Diluted)
    		 -0.93 -1.27 -1.91 -1.48
    EBITDA
    		 -16.57M -22.83M -36.57M -28.37M
    EBIT
    		 -18.34M -24.44M -39.55M -28.67M
    Depreciation & Amortization
    		 1.77M 1.6M 2.99M 296K

    Add to Watchlist